Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446128
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-16
Brief Title:
A Dose Escalating Study of CD19CD22BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin LymphomaNHL
Sponsor:
Shanghai Cell Therapy Group CoLtd
Organization:
Shanghai Cell Therapy Group CoLtd